Pharmacokinetic Evaluation of Once-Daily Topical 4% Minocycline Foam in Adult and Pediatric Subjects with Moderate-to-Severe Acne in Two Phase 1 Studies

2017 ◽  
Vol 1 ◽  
pp. s52 ◽  
Author(s):  
Terry M Jones ◽  
Herman Ellman ◽  
Tina DeVries
Keyword(s):  
Phase 1 ◽  
Two Phase ◽  
Once Daily ◽  
Severe Acne ◽  
Pharmacokinetic Evaluation

Abstract Not Available

scholarly journals Pharmacokinetic Evaluation of Once-Daily Topical 4% Minocycline Foam in Adult and Pediatric Subjects with Moderate-to-Severe Acne in Two Phase 1 Studies

2018 ◽  
Vol 2 ◽  
pp. S34
Author(s):  
Terry M Jones ◽  
Herman Ellman ◽  
Tina DeVries
Keyword(s):  
Phase 1 ◽  
Two Phase ◽  
Once Daily ◽  
Severe Acne ◽  
Pharmacokinetic Evaluation

Abstract not available. Disclosures: Study s supported by Foamix Pharmaceuticals, Inc. Copyright SKIN 2018

Tazarotene 0.045% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Results from Two Phase 3 Trials

2019 ◽  
Vol 19 (1) ◽  
pp. 70-77 ◽  
Author(s):  
Emil Tanghetti ◽  
William Werschler ◽  
Terry Lain ◽  
Eric Guenin ◽  
Gina Martin ◽  
...  
Keyword(s):  
Acne Vulgaris ◽  
Daily Treatment ◽  
Phase 3 ◽  
Two Phase ◽  
Once Daily ◽  
Severe Acne

15211 Treatment of moderate to severe acne with once-daily tazarotene 0.045% lotion in males: Pooled analysis of two phase 3 studies

2020 ◽  
Vol 83 (6) ◽  
pp. AB144
Author(s):  
Jonathan S. Weiss ◽  
Neal Bhatia ◽  
Linda Stein Gold ◽  
Gina Martin ◽  
Radhakrishnan Pillai ◽  
...  
Keyword(s):  
Pooled Analysis ◽  
Phase 3 ◽  
Two Phase ◽  
Once Daily ◽  
Severe Acne

Novel Polymeric Lotion Formulation of Once-Daily Tazarotene (0.045%) for Moderate-to-Severe Acne: Pooled Phase 3 Analysis

2020 ◽  
Vol 19 (3) ◽  
pp. 272-279
Author(s):  
Emil Tanghetti ◽  
William Werschler ◽  
Edward Lain ◽  
Eric Guenin ◽  
Susan Harris ◽  
...  
Keyword(s):  
Phase 3 ◽  
Once Daily ◽  
Severe Acne
Sign in / Sign up

Export Citation Format

Share Document